title: Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis.
abstract: We studied the effects of two antibiotic regimens on the course of Chlamydia pneumoniae infection in the lungs of Swiss Webster mice. After intranasal challenge with isolates AR-388 (1.3 x 10(7) inclusion-forming units per mouse) and AR-39 (1.5 x 10(6) inclusion-forming units per mouse), groups of animals were treated with either doxycycline (10 mg/kg of body weight once a day for 3 days), azithromycin (10 mg/kg [single dose]), or saline. Responses were assessed by the isolation of organisms in cell culture, detection of TWAR DNA in lung tissues by PCR, and lung histology. Both regimens were effective in clearing infections induced by AR-388 (P = 0.02 and 0.007 for doxycycline and azithromycin, respectively) compared with controls. TWAR DNA was detected in 77 and 25% of culture-negative lungs 2 weeks after treatment of AR-388 and AR-39 infections, respectively. Histological changes showed interstitial pneumonitis and were similar over time for all groups. Single-dose azithromycin produced drug levels in lung tissues above the MICs for the test strains for a period three times longer than that of single-dose doxycycline. We concluded that short-term antibiotic regimens were successful for the treatment of experimental TWAR pneumonitis in mice. TWAR DNA was frequently recovered from lung tissues after apparently successful treatment.
authors.affiliation: Department of Pathobiology, University of Washington, Seattle 98195.
authors.forename: R
authors.initials: R
authors.lastname: Malinverni
authors.forename: C C
authors.initials: CC
authors.lastname: Kuo
authors.forename: L A
authors.initials: LA
authors.lastname: Campbell
authors.forename: A
authors.initials: A
authors.lastname: Lee
authors.forename: J T
authors.initials: JT
authors.lastname: Grayston
mesh_terms: D000818:Animals; D017963:Azithromycin / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002690:Chlamydia Infections / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D016993:Chlamydophila pneumoniae / Q000187:drug effects*; D004269:DNA, Bacterial / Q000032:analysis; D004318:Doxycycline / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D008826:Microbial Sensitivity Tests; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
chemical_list: D004269:DNA, Bacterial; D017963:Azithromycin; D004318:Doxycycline